The Effects of Melatonin in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial

Angulo, 2002, N Engl J Med, Nonalcoholic fatty liver disease, 1221

Gonciarz, 2010, J Physiol Pharmacol, The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: Effect on plasma levels of liver enzymes, lipids and melatonin, 705

Ong, 2007, Clin Liver Dis, Epidemiology and natural history of NAFLD and NASH, 1

Ascha, 2010, Hepatology, The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis, 1972

Bedogni, 2005, Hepatology, Prevalence of and risk factors for nonalcoholic fatty liver disease: The dionysos nutrition and liver study, 44

Shen, 2003, World J Gastroenterol, Prevalence of nonalcoholic fatty liver among administrative officers in Shanghai: An epidemiological survey, 1106

Omagari, 2002, J Gastroenterol Hepatol, Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics, 1098

Lai, 2002, South Med J, Epidemiology of fatty liver in a hospital-based study in Taiwan, 1288

Bosch, 2004, Gastroenterology, Primary liver cancer: Worldwide incidence and trends, S5

Bellentani, 2010, Dig Dis, Epidemiology of non-alcoholic fatty liver disease, 155

Berlanga, 2014, Clin Exp Gastroenterol, Molecular pathways in non-alcoholic fatty liver disease, 221

Zaitone, 2011, Eur J Pharmacol, Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease, 70

Dowman, 2010, QJM, Pathogenesis of non-alcoholic fatty liver disease, 71

Arendt, 2011, Am J Gastroenterol, Effect of atorvastatin, Vitamin E and C on nonalcoholic fatty liver disease: Is the combination required?, 78

Duvnjak, 2009, J Physiol Pharmacol, Therapy of nonalcoholic fatty liver disease: Current status, 57

Sanyal, 2010, N Engl J Med, Pioglitazone, Vitamin E, or placebo for nonalcoholic steatohepatitis, 1675

Rodriguez, 2004, J Pineal Res, Regulation of antioxidant enzymes: A significant role for melatonin, 1

Tomás-Zapico, 2005, J Pineal Res, A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes, 99

Hatzis, 2013, World J Hepatol, Melatonin attenuates high fat diet-induced fatty liver disease in rats, 160

Hoyos, 2000, J Pineal Res, Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats, 150

Sener, 2004, J Pineal Res, Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice, 212

Pagadala, 2009, Clin Liver Dis, Predictors of steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease, 591

Gonciarz, 2012, J Physiol Pharmacol, The effects of long-term melatonin treatment on plasma liver enzymes levels and plasma concentrations of lipids and melatonin in patients with nonalcoholic steatohepatitis: A pilot study, 35

Nobili, 2008, Hepatology, Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: A randomized, controlled trial, 119

Promrat, 2010, Hepatology, Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis, 121

Pan, 2006, J Pineal Res, Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats, 79

Sewerynek, 1996, Hepatogastroenterology, Oxidative damage in the liver induced by ischemia-reperfusion: Protection by melatonin, 898

Celinski, 2014, J Physiol Pharmacol, Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease – 14 months follow up, 75